CN1545934A - Health products containing edible vinegar - Google Patents
Health products containing edible vinegar Download PDFInfo
- Publication number
- CN1545934A CN1545934A CNA2003101064712A CN200310106471A CN1545934A CN 1545934 A CN1545934 A CN 1545934A CN A2003101064712 A CNA2003101064712 A CN A2003101064712A CN 200310106471 A CN200310106471 A CN 200310106471A CN 1545934 A CN1545934 A CN 1545934A
- Authority
- CN
- China
- Prior art keywords
- vinegar
- purification
- composition
- essential oil
- health products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a health product containing edible vinegar composition, wherein the composition comprises purified edible vinegar (dry weight) 5%-75%, garlic essential oil 5%-70%, phosphatidy lcholine 10%-80%, vitamin E 0.1%-1%.
Description
Technical field
The present invention relates to a kind of health products that contain the vinegar composition.
Background technology
Existing health products with effects such as softening blood vessel, reduction blood fat adopt the higher nourishing healthy raw material of a cost mostly, and its cost is higher, and the collocation owing to various compositions simultaneously is unreasonable, and its nourishing healthy effect also is difficult to give full play to.
Summary of the invention
Technical problem to be solved by this invention is, a kind of health products that contain the vinegar composition that have softening blood vessel, reduce the blood fat effect are provided, make that its cost of material is lower, the nutrition collocation rationally, health-care effect is better.
A mix proportion scheme of health products of the present invention is:
Purification vinegar (dry weight) 5%～75% (weight ratio, down together)
Garlic essential oil 5%～70%
Lecithin 10%～80%
Vitamin E 0.1%～1%,
Described garlic essential oil is a garlic P.E, and wherein the content of allicin is 8%～45%; The content of phosphatidyl choline is 5%～40% in the described lecithin; Described purification vinegar is to be raw material to make vinegar, and obtains after removing moisture content.
Another mix proportion scheme of health products of the present invention is that the lecithin in the above-mentioned the first string is replaced with safflower oil, and the shared weight ratio of safflower oil is 10%～70%.
The present invention has following effect: in (one) garlic essential oil contained methacrylic trithio (MATS) and 4,5,9-trithiadodeca-1,6,11-triene 9-oxide they can suppress thrombosis, simultaneously the sulfide compound formed of its contained phenols and multiple pi-allyl, propyl group, methyl has the effect of significant reducing blood lipid, softening blood vessel, thrombus dissolving; (2) the purification vinegar is a raw material to make vinegar, not only cost is lower for it, and contain several amino acids owing in its composition, particularly contain the amino acid that the part human body can't synthesize, it concentrates the back of purifying through high power softening blood vessel, reduction blood fat is had effect preferably; (3) phosphatidyl choline in the lecithin and unrighted acid are very effective to the brain information transmission and the removing blood fat of human body; (4) safflower oil is to be raw material with the Xinjiang safflower, and the fat that its unrighted acid that contains can reduce in the human body is hoarded.
The specific embodiment
Embodiment one:
Contained composition and ratio are
Purification vinegar (dry weight) 15%
Garlic essential oil 60%
Safflower oil 24%
Vitamin E 1%.
Embodiment two:
Contained composition and ratio are
Purification vinegar (dry weight) 35%
Garlic essential oil 40%
Safflower oil 24.5%
Vitamin E 0.5%.
Embodiment three:
Contained composition and ratio are
Purification vinegar (dry weight) 20%
Garlic essential oil 5%
Lecithin 74.5%
Vitamin E 0.5%.
Embodiment four:
Contained composition and ratio are
Purification vinegar (dry weight) 70%
Garlic essential oil 10%
Safflower oil 19.5%
Vitamin E 0.5%.
In the above-described embodiments, the content of allicin is 30% in the garlic essential oil.The content of phosphatidyl choline is 25% in the lecithin.The purification vinegar is to be raw material to make vinegar, and removes its moisture content and obtains, and purification can be adopted following two kinds of methods: a kind of is to adopt spray drying process to form the vinegar powder; Another kind is that the raw material that makes vinegar is concentrated into thick vinegar liquid or vinegar cream carrying out vacuum below 60 ℃.The purification vinegar of different shape should consider that water content calculates its dry weight.
The reality of the above embodiment of the present invention is used the people, takes continuously under the normal condition 90 days, all produces the significantly effect of softening blood vessel, reduction blood fat, raising resistance.
Claims (2)
1, a kind of health products that contain the vinegar composition is characterized in that: include purification vinegar (dry weight) 5%～75% (weight ratio, down together) in its composition
Garlic essential oil 5%～70%
Lecithin 10%～80%
Vitamin E 0.1%～1%,
Described garlic essential oil is a garlic P.E, and wherein the content of allicin is 8%～45%; The content of phosphatidyl choline is 5%～40% in the described lecithin; Described purification vinegar is to be raw material to make vinegar, and obtains after removing moisture content.
2, a kind of health products that contain the vinegar composition is characterized in that: include in its composition
Purification vinegar (dry weight) 5%～75% (weight ratio, down together)
Garlic essential oil 5%～70%
Safflower oil 10%～70%
Vitamin E 0.1%～1%, described garlic essential oil is a garlic P.E, wherein the content of allicin is 8%～45%; Described purification vinegar is to be raw material to make vinegar, and obtains after removing moisture content.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2003101064712A CN1545934A (en) | 2003-12-01 | 2003-12-01 | Health products containing edible vinegar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2003101064712A CN1545934A (en) | 2003-12-01 | 2003-12-01 | Health products containing edible vinegar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1545934A true CN1545934A (en) | 2004-11-17 |
Family
ID=34334190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2003101064712A Pending CN1545934A (en) | 2003-12-01 | 2003-12-01 | Health products containing edible vinegar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1545934A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300294C (en) * | 2005-10-10 | 2007-02-14 | 浙江大学 | Detoxicating garlicin and its making process |
-
2003
- 2003-12-01 CN CNA2003101064712A patent/CN1545934A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300294C (en) * | 2005-10-10 | 2007-02-14 | 浙江大学 | Detoxicating garlicin and its making process |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0129666B1 (en) | Essenial fatty acid composition | |
| JP2909508B2 (en) | Krill phospholipid fractionation method | |
| US5650157A (en) | Pharmaceutical compositions and methods | |
| WO1992008470A1 (en) | Anti-inflammatory composition derived from emu oil | |
| KR102310765B1 (en) | Lipid compositions | |
| JP2021508343A (en) | Lysophosphatidylcholine composition | |
| DE60028152T2 (en) | Solid, stable and concentrated biologically digestible complex of orthosilicic acid and process for its preparation | |
| EP2272383A1 (en) | Composition Comprising Omega-7 and/or Omega-4 Fatty Acids | |
| JPH0225447A (en) | Production of highly unsaturated fatty acids | |
| WO2010010364A2 (en) | Process for the purification of oils | |
| JP2019162042A (en) | Plasmalogen-type phospholipid highly containing extract and method for producing the same | |
| DE68903378T2 (en) | INHIBITION OF CELL ADHAESION. | |
| JP2022511537A (en) | Very long chain fatty acid composition | |
| CN1714655A (en) | Ginkgo biscuit, rice biscuit and its producing method | |
| CN1545934A (en) | Health products containing edible vinegar | |
| CN1270697C (en) | Oral nano nourishing emulsion and its preparation method | |
| CN1257882C (en) | Method for synthesizing edible conjugated calcium linoleic acid | |
| Charnock et al. | Omega-3 PUFA's reduce the vulnerability of the rat heart to ischaemic arrhythmia in the presence of a high intake of saturated animal fat | |
| JPH0327538B2 (en) | ||
| JPH0336493B2 (en) | ||
| CN1175755C (en) | Garlic deodorizing method and garlic functional food | |
| CN1665495A (en) | A process for preparing long chain saturated or unsaturated oxygenated compounds | |
| CN100344767C (en) | Rich alpha-linolenic acid contained polyene phosphatidylcholine and its production method | |
| JP2005179340A (en) | Production method for lipid composition | |
| CN1228057C (en) | Compound of solanesol and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |